Microcrystalline L-Tyrosine Di-adjuvant

This product is specifically described as a micronized tyrosine and 3D-MPLA di-adjuvant, making it distinct from simple tyrosine-only formulations. The inclusion of 3D-MPLA and its AS04 alternative positioning make it more relevant for advanced adjuvant comparison and vaccine formulation research.

Yes, the product is explicitly positioned as an AS04 alternative, which makes it suitable for benchmarking, comparative immunology studies, and formulation screening where an AS04-like reference is required.

It is intended for vaccine adjuvant research, formulation development, and preclinical evaluation. Researchers may use it to study immune response enhancement, dispersion properties, and compatibility within experimental vaccine systems.

Research grade indicates that the product is предназначed for laboratory and development use rather than consumer or therapeutic use. It is appropriate for experimental work, R&D procurement, and scientific evaluation.

Micronized tyrosine typically supports finer particle handling and more uniform formulation behavior. In research applications, this can be valuable for improving consistency during adjuvant development and testing.